Chris Board

Linebacker

Age: 30
Free Agency: 2027 (UFA)
Accrued Seasons: 8
  • 2025 Salary Cap Charge: $2,350,000 (0.81% of cap)
  • 2025 Cash Payout: $3,100,000 (1.04% of spending)
  • 2025 Cash to Cap Ratio: 1.32
  • Contract Value: $5,700,000 ($2,850,000 APY)
  • Fully Guaranteed Money: $4,050,000
  • Contract Ranking: 52/226 at LB

Current Contract

(UFA, signed 2025)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202530$1,550,000$750,000$50,000$1,550,000$2,350,0000.8%
202631$2,550,000$750,000$50,000$500,000$3,350,0001.1%
Total$4,100,000$1,500,000$100,000$2,050,000$5,700,000

Contract Notes

Chris Board signed a two year, $5.7 million contract with the Giants. $3.55 million is guaranteed.

Cash Flows

- fully earned money
- unearned or partially earned money
$2.9M
$5.7M
20252026
Cash Due$3,100,000$2,600,000
Running Cash$3,100,000$5,700,000
Career Earnings: $13,419,500
Career APY: $1,677,438
Potential Earnings: $15,579,500
Total Guarantees: $10,489,500
Largest Cash Payment: $3,100,000 (2025)
Largest Cap Number: $3,350,000 (2026)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RavensUDFAExpired20183$1,714,000$571,333$4,000$1,804,000105.3%$601,333
RavensRFAExpired20211$1,683,000$1,683,000$1,683,000$2,183,000129.7%$2,183,000
LionsUFAExpired20221$2,000,000$2,000,000$1,000,000$2,000,000100.0%$2,000,000
PatriotsUFATerminated20232$5,000,000$2,500,000$2,600,000$2,600,00052.0%$2,600,000
RavensSFAExpired20241$1,292,500$1,292,500$1,152,500$1,292,500100.0%$1,292,500
GiantsUFAActive20252$5,700,000$2,850,000$4,050,000$3,100,00054.4%$3,100,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Ravens5$5,279,500$1,055,900$4,639,5000.0%$00.0%
Lions1$2,000,000$2,000,000$2,000,0000.0%$00.0%
Patriots1$3,040,000$3,040,000$2,102,5000.0%$937,5000.0%
Giants1$3,100,000$3,100,000$2,350,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2018Ravens$480,000$1,333$0$0$0$481,3330.3%$484,000
2019Ravens$570,000$1,333$0$0$0$571,3330.3%$570,000
2020Ravens$750,000$1,334$0$0$0$751,3340.4%$750,000
2021Ravens$1,183,000$500,000$0$0$1,183,000$1,683,0000.9%$2,183,000
2022Lions$1,500,000$400,000$100,000$0$600,000$2,000,0000.9%$2,000,000
2023Patriots$1,165,000$497,500$340,000$100,000$1,165,000$2,102,5000.9%$2,600,000
2024Ravens$1,125,000$167,500$0$0$985,000$1,152,5000.5%$1,292,500
2025Giants$1,550,000$750,000$0$50,000$1,550,000$2,350,0000.8%$3,100,000
2026Giants$2,550,000$750,000$0$50,000$500,000$3,350,0001.1%$2,600,000
Total$10,873,000$3,069,000$440,000$200,000$5,983,000$14,442,000$15,579,500
Dead Money History
TeamYearCap ChargeCash Paid
Patriots2024$937,500$440,000
Total$937,500$440,000

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
DefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
20181601.4%79.8%4200000000000
20191516.6%66.8%6400100001000
202016024.5%78.9%1592.511251001000
202116030.9%80.6%131700020000000
202216013.2%76.3%11000011001000
20231700.1%83.7%0000000000000
202417014.8%80.4%101019211000000
2025201.3%9.9%1000000000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$569,000$2,850,000
Injury Adjusted$569,000$2,850,000
test
OTC Valuation $2.8M $5.7M $8.5M $11.3M $14.2M APY $3.5M $7M $10.5M $14M $17.5M $4,196,000 $3,125,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.